Effect and mechanism of protease inhibitor oprozomib on doxorubicin sensitivity of hepatocellular carcinoma cells

• 主要な著者: Feng Qi (著者), Sheng Zheng (著者), Lu Hou (著者), XinNian Fu (著者), XinXin Wang (著者), ZhiPeng Fu (著者), Juan Yang (著者)
• フォーマット: 図書
• 出版事項: Polskie Towarzystwo Farmaceutyczne, 2024-06-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

This study was to examine the impact of Oprozomib (OPZ), an oral second-generation proteasome inhibitor, on the sensitivity of hepatocellular carcinoma (HCC) cells to doxorubicin (DOX), a commonly used chemotherapy drug for the treatment of HCC. HCC cells were incubated with OPZ or DOX. Cell prolife...